IT firm Cerner invests in Dx maker Claritas Genomics

Boston Children's Hospital spinoff Claritas Genomics, a genetic diagnostic testing company, attracted an investment from IT specialist Cerner, and the two will collaborate to develop a computing infrastructure designed to smooth the diagnostic process from start to finish. Cerner's Millennium Helix integration software helps to order the genomic sequencing, interpret results and incorporate them into a patient's health record, according to a report from Modern Healthcare. The partnership is another example of a growing trend in which IT and diagnostics companies are joining forces for an integrated approach to product development. "Cerner has long focused on the power of genomics and its impact to clinical processes, and this relationship will help advance the field and define a meaningful narrative in personalized medicine between the realms of research, diagnostics and clinical practice," Cerner Senior Vice President Dick Flanigan said in a statement. More

Suggested Articles

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.

Philips looked back on 15 years of data from one of its telehealth-equipped intensive care units, where centralizing operations reduced mortality.

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.